Discovery of New 3,3-Diethylazetidine-2,4-dione Based Thiazoles as Nanomolar Human Neutrophil Elastase Inhibitors with Broad-Spectrum Antiproliferative Activity

A series of 3,3-diethylazetidine-2,4-dione based thiazoles <b>3a</b>–<b>3j</b> were designed and synthesized as new human neutrophil elastase (HNE) inhibitors in nanomolar range. The representative compounds <b>3c</b>, <b>3e</b>, and <b>3h</b&...

Full description

Bibliographic Details
Main Authors: Beata Donarska, Marta Świtalska, Joanna Wietrzyk, Wojciech Płaziński, Magdalena Mizerska-Kowalska, Barbara Zdzisińska, Krzysztof Z. Łączkowski
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/14/7566
_version_ 1797433517780500480
author Beata Donarska
Marta Świtalska
Joanna Wietrzyk
Wojciech Płaziński
Magdalena Mizerska-Kowalska
Barbara Zdzisińska
Krzysztof Z. Łączkowski
author_facet Beata Donarska
Marta Świtalska
Joanna Wietrzyk
Wojciech Płaziński
Magdalena Mizerska-Kowalska
Barbara Zdzisińska
Krzysztof Z. Łączkowski
author_sort Beata Donarska
collection DOAJ
description A series of 3,3-diethylazetidine-2,4-dione based thiazoles <b>3a</b>–<b>3j</b> were designed and synthesized as new human neutrophil elastase (HNE) inhibitors in nanomolar range. The representative compounds <b>3c</b>, <b>3e</b>, and <b>3h</b> exhibit high HNE inhibitory activity with IC<sub>50</sub> values of 35.02–44.59 nM, with mixed mechanism of action. Additionally, the most active compounds <b>3c</b> and <b>3e</b> demonstrate high stability under physiological conditions. The molecular docking study showed good correlation of the binding energies with the IC<sub>50</sub> values, suggesting that the inhibition properties are largely dependent on the stage of ligand alignment in the binding cavity. The inhibition properties are correlated with the energy level of substrates of the reaction of ligand with Ser195. Moreover, most compounds showed high and broad-spectrum antiproliferative activity against human leukemia (MV4-11), human lung carcinoma (A549), human breast adenocarcinoma (MDA-MB-231), and urinary bladder carcinoma (UMUC-3), with IC<sub>50</sub> values of 4.59–9.86 μM. Additionally, compounds <b>3c</b> and <b>3e</b> can induce cell cycle arrest at the G2/M phase and apoptosis via caspase-3 activation, leading to inhibition of A549 cell proliferation. These findings suggest that these new types of drugs could be used to treat cancer and other diseases in which immunoreactive HNE is produced.
first_indexed 2024-03-09T10:18:05Z
format Article
id doaj.art-2ee7c676fe8144598a0b9bff4da9e363
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T10:18:05Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-2ee7c676fe8144598a0b9bff4da9e3632023-12-01T22:14:01ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-07-012314756610.3390/ijms23147566Discovery of New 3,3-Diethylazetidine-2,4-dione Based Thiazoles as Nanomolar Human Neutrophil Elastase Inhibitors with Broad-Spectrum Antiproliferative ActivityBeata Donarska0Marta Świtalska1Joanna Wietrzyk2Wojciech Płaziński3Magdalena Mizerska-Kowalska4Barbara Zdzisińska5Krzysztof Z. Łączkowski6Department of Chemical Technology and Pharmaceuticals, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Jurasza 2, 85-089 Bydgoszcz, PolandHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wrocław, PolandHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Rudolfa Weigla 12, 53-114 Wrocław, PolandJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, 30-239 Cracow, PolandDepartment of Virology and Immunology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19 Street, 20-033 Lublin, PolandDepartment of Virology and Immunology, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University, Akademicka 19 Street, 20-033 Lublin, PolandDepartment of Chemical Technology and Pharmaceuticals, Faculty of Pharmacy, Collegium Medicum, Nicolaus Copernicus University, Jurasza 2, 85-089 Bydgoszcz, PolandA series of 3,3-diethylazetidine-2,4-dione based thiazoles <b>3a</b>–<b>3j</b> were designed and synthesized as new human neutrophil elastase (HNE) inhibitors in nanomolar range. The representative compounds <b>3c</b>, <b>3e</b>, and <b>3h</b> exhibit high HNE inhibitory activity with IC<sub>50</sub> values of 35.02–44.59 nM, with mixed mechanism of action. Additionally, the most active compounds <b>3c</b> and <b>3e</b> demonstrate high stability under physiological conditions. The molecular docking study showed good correlation of the binding energies with the IC<sub>50</sub> values, suggesting that the inhibition properties are largely dependent on the stage of ligand alignment in the binding cavity. The inhibition properties are correlated with the energy level of substrates of the reaction of ligand with Ser195. Moreover, most compounds showed high and broad-spectrum antiproliferative activity against human leukemia (MV4-11), human lung carcinoma (A549), human breast adenocarcinoma (MDA-MB-231), and urinary bladder carcinoma (UMUC-3), with IC<sub>50</sub> values of 4.59–9.86 μM. Additionally, compounds <b>3c</b> and <b>3e</b> can induce cell cycle arrest at the G2/M phase and apoptosis via caspase-3 activation, leading to inhibition of A549 cell proliferation. These findings suggest that these new types of drugs could be used to treat cancer and other diseases in which immunoreactive HNE is produced.https://www.mdpi.com/1422-0067/23/14/7566human neutrophil elastaseantiproliferative activitythiazolemolecular docking
spellingShingle Beata Donarska
Marta Świtalska
Joanna Wietrzyk
Wojciech Płaziński
Magdalena Mizerska-Kowalska
Barbara Zdzisińska
Krzysztof Z. Łączkowski
Discovery of New 3,3-Diethylazetidine-2,4-dione Based Thiazoles as Nanomolar Human Neutrophil Elastase Inhibitors with Broad-Spectrum Antiproliferative Activity
International Journal of Molecular Sciences
human neutrophil elastase
antiproliferative activity
thiazole
molecular docking
title Discovery of New 3,3-Diethylazetidine-2,4-dione Based Thiazoles as Nanomolar Human Neutrophil Elastase Inhibitors with Broad-Spectrum Antiproliferative Activity
title_full Discovery of New 3,3-Diethylazetidine-2,4-dione Based Thiazoles as Nanomolar Human Neutrophil Elastase Inhibitors with Broad-Spectrum Antiproliferative Activity
title_fullStr Discovery of New 3,3-Diethylazetidine-2,4-dione Based Thiazoles as Nanomolar Human Neutrophil Elastase Inhibitors with Broad-Spectrum Antiproliferative Activity
title_full_unstemmed Discovery of New 3,3-Diethylazetidine-2,4-dione Based Thiazoles as Nanomolar Human Neutrophil Elastase Inhibitors with Broad-Spectrum Antiproliferative Activity
title_short Discovery of New 3,3-Diethylazetidine-2,4-dione Based Thiazoles as Nanomolar Human Neutrophil Elastase Inhibitors with Broad-Spectrum Antiproliferative Activity
title_sort discovery of new 3 3 diethylazetidine 2 4 dione based thiazoles as nanomolar human neutrophil elastase inhibitors with broad spectrum antiproliferative activity
topic human neutrophil elastase
antiproliferative activity
thiazole
molecular docking
url https://www.mdpi.com/1422-0067/23/14/7566
work_keys_str_mv AT beatadonarska discoveryofnew33diethylazetidine24dionebasedthiazolesasnanomolarhumanneutrophilelastaseinhibitorswithbroadspectrumantiproliferativeactivity
AT martaswitalska discoveryofnew33diethylazetidine24dionebasedthiazolesasnanomolarhumanneutrophilelastaseinhibitorswithbroadspectrumantiproliferativeactivity
AT joannawietrzyk discoveryofnew33diethylazetidine24dionebasedthiazolesasnanomolarhumanneutrophilelastaseinhibitorswithbroadspectrumantiproliferativeactivity
AT wojciechpłazinski discoveryofnew33diethylazetidine24dionebasedthiazolesasnanomolarhumanneutrophilelastaseinhibitorswithbroadspectrumantiproliferativeactivity
AT magdalenamizerskakowalska discoveryofnew33diethylazetidine24dionebasedthiazolesasnanomolarhumanneutrophilelastaseinhibitorswithbroadspectrumantiproliferativeactivity
AT barbarazdzisinska discoveryofnew33diethylazetidine24dionebasedthiazolesasnanomolarhumanneutrophilelastaseinhibitorswithbroadspectrumantiproliferativeactivity
AT krzysztofzłaczkowski discoveryofnew33diethylazetidine24dionebasedthiazolesasnanomolarhumanneutrophilelastaseinhibitorswithbroadspectrumantiproliferativeactivity